People suffering from the more serious form of age-related macular degeneration known as wet AMD lose central vision when abnormal blood vessels sprout and leak fluid and blood into their

Age-related macular degeneration (AMD) is an eye condition that affects central vision. This results in blurry or dimmed vision and makes reading, driving and seeing fine details difficult or impossible

Some individuals with dry macular degeneration progress to wet form of the disease. This occurs when abnormal blood vessels grow and leak fluid under the retina, leading to blurry vision

An NYU Langone doctor can use a dilated eye exam as the ideal way to assess whether macular degeneration has progressed or remains stable. During this painless procedure, your physician

AMD progression can be reduced through healthy eating habits, keeping out of direct sunlight by wearing protective eyewear such as sunglasses and hats, not smoking and scheduling regular eye exams

Juvenile macular degeneration (JMD) is an eye condition which damages the macula, leading to central vision loss in one or both eyes. Symptoms usually emerge during childhood or early adolescence

Patients suffering from wet age-related macular degeneration require regular injections of medication into their eye to avoid vision loss and must adhere to an intricate treatment schedule in order to

Stargardt disease is an inherited disorder caused by mutations to the ABCA4 gene and manifests with central vision becoming blurry or distorted, without impacting peripheral vision. Eye doctors can detect

AMD is one of the leading causes of vision loss among people aged 50 or above and can eventually lead to blindness in its advanced stages. Current treatments for wet

One dose of anti-VEGF drug Aflibercept (Eylea) typically costs from $1,850 – $2,200 retail while bevacizumab (Avastin) typically ranges from $55 retail. Genetic testing could result in a net financial